Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Colonization and Infection With Extensively Drug Resistant Gram-Negative Bacteria in Liver Transplant Recipients.
Massa E, Michailidou E, Agapakis D, Papadopoulos S, Tholioti T, Aleuroudis I, Bargiota T, Passakiotou M, Daoudaki M, Antoniadis N, Imvrios G, Iosifidis E, Vagdatli E, Roilides E, Vasilakos D, Fouzas I, Mouloudi E. Massa E, et al. Among authors: agapakis d. Transplant Proc. 2019 Mar;51(2):454-456. doi: 10.1016/j.transproceed.2019.01.076. Epub 2019 Jan 28. Transplant Proc. 2019. PMID: 30879565
Perioperative Chemoprophylaxis οr Treatment for Extensively Drug Resistant Gram-Negative Bacteria in Patients Undergoing Liver Transplantation Based on Preoperative Donor/Recipient Surveillance Cultures: A Prospective Study.
Massa E, Michailidou E, Papadopoulos S, Agapakis D, Kotsamidi I, Xarisopoulos D, Iosifidis E, Daoudaki M, Philis D, Imvrios G, Vagdatli E, Vasilakos D, Papanikolaou V, Fouzas I, Mouloudi E. Massa E, et al. Among authors: agapakis d. Transplant Proc. 2019 Mar;51(2):457-460. doi: 10.1016/j.transproceed.2019.01.077. Epub 2019 Jan 28. Transplant Proc. 2019. PMID: 30879566
Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH.
Anagnostis P, Rizos CV, Skoumas I, Rallidis L, Tziomalos K, Skalidis E, Kotsis V, Doumas M, Kolovou G, Sfikas G, Garoufi A, Lambadiari V, Dima I, Kiouri E, Agapakis D, Zacharis E, Antza C, Kolovou V, Koumaras C, Bantouvakis G, Liamis G, Liberopoulos EN. Anagnostis P, et al. Among authors: agapakis d. Endocrine. 2022 May;76(2):324-330. doi: 10.1007/s12020-022-03013-y. Epub 2022 Mar 9. Endocrine. 2022. PMID: 35262845
LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments.
Rizos CV, Skoumas I, Rallidis L, Skalidis E, Tziomalos K, Garoufi A, Anagnostis P, Sfikas G, Kotsis V, Doumas M, Kolovou G, Lambadiari V, Dima I, Kiouri E, Zacharis E, Agapakis D, Attilakos A, Antza C, Vlachopoulos C, Liberopoulos EN. Rizos CV, et al. Among authors: agapakis d. Int J Cardiol. 2021 Dec 15;345:119-124. doi: 10.1016/j.ijcard.2021.10.024. Epub 2021 Oct 21. Int J Cardiol. 2021. PMID: 34687802
Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH.
Anagnostis P, Rizos CV, Skoumas I, Rallidis L, Tziomalos K, Skalidis E, Kotsis V, Doumas M, Kolovou G, Sfikas G, Bilianou E, Koutagiar I, Agapakis D, Zacharis E, Antza C, Koumaras C, Boutari C, Liamis G, Liberopoulos EN. Anagnostis P, et al. Among authors: agapakis d. Curr Pharm Des. 2021;27(21):2537-2544. doi: 10.2174/1381612827666210216151645. Curr Pharm Des. 2021. PMID: 33593250
21 results